文献速递瓣膜外科

心室颤动停搏:机器人全内镜心内手术中的安全选择

Ventricular Fibrillatory Arrest: A Safe Option in Robotic Totally Endoscopic Intracardiac Surgery.
PubMed 文献 · Ann Thorac Surg · 2022-12-17

该研究回顾了2014年2月至2022年7月共128例在机器人全内镜心内手术中使用中度低温心室颤动停搏的患者经验,患者平均年龄65±14岁,平均STS评分2.7±2.9。结果显示无中转开胸,术后无卒中或临床心肌梗死,仅1例死亡(0.78%),作者认为对于经选择的患者该技术可能是安全有效的替代方案。

要点

  • 128例机器人全内镜心内手术采用中度低温心室颤动停搏,无中转开胸。
  • 术后无卒中或临床心肌梗死,仅1例死亡(0.78%)死于呼吸衰竭。
  • 作者认为对于经选择的患者,该技术可能是安全有效的替代方案。

核心结论

  • 作者认为,在机器人心内手术中使用中度低温心室颤动停搏,对于经选择的患者可能是安全有效的替代方案。

研究设计与样本

  • 回顾性分析2014年2月至2022年7月共128例采用中度低温心室颤动停搏行机器人全内镜心内手术的患者。
  • 患者选择基于主动脉操作风险、手术复杂性、主动脉瓣反流程度及合并症(包括既往心脏手术史和外周血管疾病)。

主要发现

  • 患者平均年龄65±14岁,平均STS评分2.7±2.9。
  • 14例(11%)有既往心脏手术史。
  • 心内手术类型:二尖瓣手术84例(66%),孤立冷冻迷宫手术27例(21%),其他17例(13%)。
  • 平均心室颤动停搏时间79±26分钟,平均体外循环时间174±49分钟。
  • 无中转开胸;7例(5.5%)需要正性肌力药物支持,2例(1.6%)需要主动脉内球囊反搏。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Moderate hypothermic ventricular fibrillatory arrest during heart surgery is an alternative to cardioplegic arrest in selected patients. We reviewed our experience using a ventricular fibrillatory arrest technique in robotic totally endoscopic intracardiac surgery. METHODS: From February 2014 through July 2022, 128 patients who underwent robotic totally endoscopic intracardiac surgical procedures performed using moderate hypothermic ventricular fibrillatory arrest were reviewed. Patients were chosen based on the risk of aortic manipulation, complexity of the procedure, grade of aortic valve insufficiency and comorbidities, including history of prior cardiac surgery and peripheral vascular disease. RESULTS: Patients were a mean age of 65 ± 14 years, and the mean The Society of Thoracic Surgeons score was 2.7 ± 2.9. Fourteen patients (11%) had a history of previous cardiac surgery. The intracardiac procedures were mitral valve surgery in 84 patients (66%), isolated cryomaze procedure in 27 (21%), and other in 17 (13%). The mean ventricular fibrillatory arrest time was 79 ± 26 minutes, and the mean cardiopulmonary bypass time was 174 ± 49 minutes. There was no conversion to sternotomy. Seven patients (5.5%) required inotropic support, and 2 patients (1.6%) needed an intra-aortic balloon pump. There was no incidence of postoperative stroke or clinical myocardial infarction. The mean hospital and intensive care unit lengths of stay were 3.1 ± 1.7 and 1.4 ± 0.7 days, respectively. One death (0.78%) occurred due to respiratory failure. CONCLUSIONS: Moderate hypothermic ventricular fibrillatory arrest in robotic intracardiac surgery may be a safe and effective alternative in selected patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kitahara H, Nisivaco S, Piech R, et al. Ventricular Fibrillatory Arrest: A Safe Option in Robotic Totally Endoscopic Intracardiac Surgery. Ann Thorac Surg. 2022. PMID: 36539048. doi:10.1016/j.athoracsur.2022.12.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。